EP2712611A1 — Stabilized aqueous compositions of neuromuscular blocking agents
Assigned to B Braun Melsungen AG · Expires 2014-04-02 · 12y expired
What this patent protects
The invention relates to an aqueous composition comprising a quaternary ammonium blocking agent and a polyhydroxy acid based excipient, and a method for producing said composition. In particular the neuromuscular blocking agent may be a Rocuronium salt and the excipient is an ald…
USPTO Abstract
The invention relates to an aqueous composition comprising a quaternary ammonium blocking agent and a polyhydroxy acid based excipient, and a method for producing said composition. In particular the neuromuscular blocking agent may be a Rocuronium salt and the excipient is an aldonic acid, e. g. gluconic acid or an intramolecular lactone thereof. Furthermore, the invention relates to a liquid pharmaceutical composition comprising said aqueous composition. The compositions of the present invention can further be comprised in a container made of glass or an organic polymer. Additionally, the invention relates to a pharmaceutical kit comprising the compositions of the present invention.
Drugs covered by this patent
- Rocuronium (Rocuronium Bromide) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.